Supreme Court Backs Maker of Generic Heart Drug in ‘Skinny Label’ Case
Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin’s patents for its anti-hypertriglyceridemia drug icosapent ethyl (Vascepa), the Supreme Court…


![[Partner Post] OD Perspective: The Changing Landscape of Myopia Management](https://www.healthmkts.com/wp-content/uploads/2026/06/Partner-Post-OD-Perspective-The-Changing-Landscape-of-Myopia-Management.jpg)






